Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
UMP Healthcare HoldingsHKSE:00722 56 EV-to-FCF is 1.35 as of Aug. 16, 2026, which is 75% below its 10-year median of 5.30. GuruFocus rates HKSE:00722 with a GF Score™ of 56/100 and a GF Value™ of HK$0.49 (Fairly Valued). The stock has 6 warning signs investors should review. Among 410 Healthcare Providers & Services companies, UMP Healthcare Holdings ranks better than 96.1% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, UMP Healthcare Holdings's Enterprise Value is HK$154.0 Mil.
UMP Healthcare Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$114.0 Mil. Therefore, UMP Healthcare Holdings's EV-to-FCF for today is 1.35.
The historical rank and industry rank for UMP Healthcare Holdings's EV-to-FCF or its related term are showing as below:
HKSE:00722'
s EV-to-FCF Range Over the Past 10 Years
Min: -11.96 Med: 5.3 Max: 365.08
Current: 1.35
During the past 11 years, the highest EV-to-FCF of UMP Healthcare Holdings was 365.08. The lowest was -11.96. And the median was 5.30.
HKSE:00722's EV-to-FCF is ranked better than 96.1% of 410
companies
in the Healthcare Providers & Services industry
Industry Median: 18.77
vs HKSE:00722: 1.35
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
UMP Healthcare Holdings's PE Ratio (TTM) for today is calculated as:
UMP Healthcare Holdings's share price for today is HK$0.445.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. UMP Healthcare Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.041.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, UMP Healthcare Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UMP Healthcare Holdings EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, UMP Healthcare Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where UMP Healthcare Holdings's EV-to-FCF falls into.
UMP Healthcare Holdings's current Enterprise Value is HK$154.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. UMP Healthcare Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$114.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UMP Healthcare Holdings (HKSE:00722) has a EV-to-FCF of 1.35 as of Aug. 16, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on UMP Healthcare Holdings and its competitors. This is 75% below median its historical median of 5.30. According to the industry distribution chart, UMP Healthcare Holdings ranks #16 out of 410 companies in the Healthcare Providers & Services industry, placing it in the top 3.9%.
Is UMP Healthcare Holdings' EV-to-FCF too high?
UMP Healthcare Holdings' current EV-to-FCF of 1.35 is 75% below median its 10-year median of 5.30. The Healthcare Providers & Services industry median EV-to-FCF is 18.77. UMP Healthcare Holdings' value of 1.35 is 92.8% below this industry median. Based on the distribution chart, UMP Healthcare Holdings ranks #16 out of 410 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, UMP Healthcare Holdings has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does UMP Healthcare Holdings' EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, UMP Healthcare Holdings ranks #16 out of 410 companies for EV-to-FCF. This places UMP Healthcare Holdings in the top 4% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 18.77. UMP Healthcare Holdings' value of 1.35 is 92.8% below this benchmark. While the company's 10-year median is 5.30 vs. the industry median of 18.77, UMP Healthcare Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.77, based on 410 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. UMP Healthcare Holdings's current EV-to-FCF of 1.35 is 92.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on UMP Healthcare Holdings and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UMP Healthcare Holdings's current EV-to-FCF is 1.35, which is 75% below median its own 10-year median of 5.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UMP Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, UMP Healthcare Holdings (HKSE:00722) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.49, compared to a current price of HK$0.45 — trading 9.2% below its estimated fair value. The current EV-to-FCF is 1.35, which is 75% below median its 10-year median of 5.30 and 92.8% below the Healthcare Providers & Services industry median of 18.77. UMP Healthcare Holdings' overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For UMP Healthcare Holdings (HKSE:00722), the current EV-to-FCF is 1.35 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is UMP Healthcare Holdings (HKSE:00722) Overvalued in 2026?
Based on GuruFocus' analysis, UMP Healthcare Holdings stock appears to be undervalued.
The current stock price of HK$0.45 is trading 9.2% below its estimated GF Value™ of HK$0.49.
GuruFocus considers UMP Healthcare Holdings to be Fairly Valued.
Key valuation signals for HKSE:00722:
EV-to-FCF: 1.35 (75% below median its 10-year median of 5.30)
GF Value™: HK$0.49 vs. price of HK$0.45 (9.2% below fair value)
Industry Position: 92.8% below the Healthcare Providers & Services median (#16 of 410)
No single metric tells the full story. See the HKSE:00722 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UMP Healthcare Holdings Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the provision of healthcare services that include corporate healthcare solution services, medical and dental services, medical imaging and laboratory services, other auxiliary medical services, and healthcare management services. The reportable operating business segments are Hong Kong & Macau Clinical Healthcare Services, which derives maximum revenue; Hong Kong & Macau Corporate Healthcare Solution Services; and Mainland China Clinical Healthcare Services. Its geographical segments include Hong Kong, Mainland China, and Macau, of which the majority of its revenue comes from Hong Kong.
56GF Score
Get the complete analysis for HKSE:00722
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00722 has been successfully added to your 
